Founded in 2017, Barcode has developed delivery and screening tools for anti-cancer DNA-labeled drugs
We are one of a few companies in the world which can integrate the advances in lipid nanoparticles with formulation screening, tissue analysis and bioinformatics abilities.
Our scientific and research team
Barcode nanotech's management & researchers and scientists.
CEO AND CO-FOUNDER
Ronen Eavri, Ph.D. MBA
Leading new product development in pharmaceutical and medical device companies for over 10 years (formally: J&J and D-Pharm) .
Scientific education from the Hebrew University, Technion and MIT.
CTO AND CO-FOUNDER
Annie Sabbah, Ph.D.
Former CTO of MPT Diagnostics and Lab Research Manager at Rambam Campus (Technion). Expert in microparticles and molecular biology.
Scientific education from the Technion.
R&D TEAM LEADER
Felix Badinter M.Sc.
M.Sc. in Biotechnology from the Technion.
Over 8 years of industrial experience in Research and Development in the fields of biotech and nanotechnology.
ANALITICAL CHEMISTRY LEAD
Valeria Rukhman Ph.D.
Ph.D. in Biochemistry from the faculty of Chemistry of the Technion.
Over 15 years of experience in pharmaceutical QC laboratories.
Or Rosen M.Sc.
M.Sc. in Biotechnology from the Tel-Hai.
Experienced in various chemical and biological processes.